Cybergenics
This article was originally published in The Tan Sheet
Executive Summary
L&S Research receives FDA warning letter for Super Water Pill Caplets, Fusion Multi-Power Tablets, Cyberblast Capsules, Super Fat-Loss Tablets, QuickTrim Complex #1-#4 Caplets, CyberTrim Formulas #1-#4 Tablets, Mega-Fat Burner Tablets, Protabalase (EM and ME formulas) and Palm Springs Elite Total Diet Plan (AM and PM formulas). FDA stated that labeling and promotional materials for the items indicate that they are unapproved new drugs. FDA asked L&S to provide its "intentions for the continued promotion and marketing of these products as OTC weight control drug products"
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning